proprietary

MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity

Company builds on earlier GLP-1 success with breakthrough AI-led insights into aging biology -- targeting the widely projected $60B longevity…

4 days ago

EverBridge Group and Cosmotec Forge Landmark Partnership

SHANGHAI, Sept. 15, 2025 /PRNewswire/ -- EverBridge Group announced an Exclusive Commercialization Partnership with Cosmotec Inc. (a Wholly Owned Subsidiary…

5 days ago

Navia Markets Unveils ‘Navia All-in-1 Trade & Invest’ App – A Next-Gen Zero Brokerage Trading & Investing Platform

CHENNAI, India, Sept. 19, 2025 /PRNewswire/ -- Navia Markets Ltd., a trusted name in Indian financial services with a legacy…

6 days ago

Akumin Selected to Exhibit Akumin AXIS at Vizient Innovative Technology Exchange

PLANTATION, Fla.--(BUSINESS WIRE)--Akumin Inc. (“Akumin” or the “Company”), a leader in managed radiology and oncology services, has been selected to…

2 weeks ago

ACM Research Delivered Its First High-Throughput Ultra Lith KrF Track System to a Leading Chinese Logic Wafer Fab Customer

September 07, 2025 20:00 ET  | Source: ACM Research, Inc. New Ultra Lith KrF Track System Delivers High-Throughput Performance with…

3 weeks ago

Formed for Feel: Cleveland Golf Introduces CBZ Wedges with ZAlloy

HUNTINGTON BEACH, Calif., Aug. 26, 2025 – Cleveland Golf is once again setting a new standard in short game innovation…

4 weeks ago

LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager

Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced…

1 month ago

L&T Technology Services Launches PLxAI, Proprietary GenAI Framework to Accelerate Product Development

PLxAI accelerates product development across the life cycle stages; versatile architecture makes it adaptable for Embedded and Software PDLCBANGALORE, India--(BUSINESS…

1 month ago

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…

1 month ago

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

2 months ago